Table 2.
Associations between intake of total artificial sweeteners, aspartame, acesulfame potassium, and sucralose and overall cardiovascular diseases, coronary heart diseases and cerebrovascular diseases, NutriNet-Santé cohort, France, 2009-21 (n=103 388)
Outcome and exposure | Hazard ratio (95% CI) | P value |
---|---|---|
Cardiovascular diseases (n=1502) | ||
Total artificial sweeteners | 1.09 (1.01 to 1.18) | 0.03 |
Aspartame | 1.03 (0.94 to 1.14) | 0.49 |
Acesulfame potassium | 1.18 (0.98 to 1.41) | 0.08 |
Sucralose | 1.11 (0.92 to 1.34) | 0.28 |
Coronary heart diseases (n=730) | ||
Total artificial sweeteners | 1.02 (0.91 to 1.14) | 0.79 |
Aspartame | 0.91 (0.78 to 1.06) | 0.22 |
Acesulfame potassium | 1.40 (1.06 to 1.84) | 0.02 |
Sucralose | 1.31 (1.00 to 1.71) | 0.05 |
Cerebrovascular diseases (n=777) | ||
Total artificial sweeteners | 1.18 (1.06 to 1.31) | 0.002 |
Aspartame | 1.17 (1.03 to 1.33) | 0.02 |
Acesulfame potassium | 1.01 (0.79 to 1.29) | 0.93 |
Sucralose | 0.99 (0.76 to 1.29) | 0.93 |
Median follow-up times for overall cardiovascular, coronary heart, and cerebrovascular diseases were all 9.0 years; person years were 904 205, 904 270, and 904 259, respectively. Exposure was coded as log10 of artificial sweetener intake in mg/day+1. Main models were adjusted for age (time scale), sex, physical activity (categorical: International Physical Activity Questionnaire variable: high, moderate, low, missing value), smoking status (categorical: never, former, current smoker), number of smoked cigarettes in pack years (continuous), higher educational level (categorical: less than high school degree, <2 years after high school degree, ≥2 years after high school degree), family history of cardiovascular disease (categorical: yes, no), energy intake without alcohol (continuous: kcal/day), daily intakes (continuous: g/day) of alcohol, sodium, saturated fatty acids, polyunsaturated fatty acids, fibre, sugar, fruit and vegetables, red and processed meat. Models were also mutually adjusted for sweetener intake other than the one studied (continuous).